InfuSystem Holdings, Inc.

AMEX:INFU

Medical - Instruments & Supplies

Healthcare
$14.67 +4.00%

+$0.35 today

Market cap
$293.89M
Beta
1.42
P/E (TTM)
23.2
EPS (TTM)
$0.39
52W Low $5.38High $11.04

Volume 0.16M

Average 0.16M

INFU Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

InfuSystem Holdings, Inc.AMEX: INFU

Gross Margin · Q1 FY2026 · quarter ended Mar 2026

Gross margin widens to 58.4%

Gross margin was 58.4% in Q1 FY2026, up 3.2 pp from a year earlier. On a trailing-twelve-month basis it was 56.7%, up 3.6 pp year over year. Over 3 fiscal years it widened by 0.9 pp.

Context

  • Gross margin widened in 2 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
58.4%+2.0 pp QoQ
Last fiscal yearDec 2025
56.0%+3.8 pp YoY
LTMMar 2026
56.7%+3.6 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+3.2 pp——
1 year+3.8 pp——
3 years+0.9 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
56.0%
Year-over-year change
+3.8pp

Gross Margin vs competitors

How INFU compares with its peers on the latest reported figures

  • INFU's LTM Mar 2026 gross margin of 56.7% is the 2nd highest of the 3 companies compared; the peer median is 49.5%.
  • Its year-over-year change of +3.6 pp is the highest of 3, against a peer median of -0.1 pp.
  • Over three fiscal years its change of +0.9 pp compares with a peer median of +6.7 pp.
INFU Competitors Peer median
Gross Margin for INFU and competitors
Company Period LTM level YoY 3-year change
KRMDKORU Medical Systems, Inc.LTM Mar 202661.5% -2.0 pp+7.2 pp
INFUInfuSystem Holdings, Inc.LTM Mar 202656.7% +3.6 pp+0.9 pp
ICUIICU Medical, Inc.LTM Jun 202637.6% +1.7 pp+6.2 pp
Peer median (excluding INFU) 49.5%-0.1 pp+6.7 pp

Competitors are the stored peer set for INFU. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue102.38M109.91M125.79M134.86M143.44M
Cost of Revenue43.85M49.35M62.68M64.46M63.14M
Gross Profit58.54M60.56M63.11M70.4M80.3M
Gross Margin57.2%55.1%50.2%52.2%56.0%
Research & Development00000
Selling, General & Admin51.45M56.41M58.03M62.52M67.46M
Operating Expenses55.72M58.91M59.02M63.51M68.38M
Depreciation & Amortization14.63M13.36M12.51M12.5M13.29M
EBITDA17.26M14.89M16.53M20.03M25.22M
EBITDA Margin16.9%13.5%13.1%14.9%17.6%
Operating Income2.82M1.65M4.09M6.89M11.92M
Operating Margin2.8%1.5%3.2%5.1%8.3%
Interest Income00000
Interest Expense1.38M1.4M2.17M1.78M1.3M
Other Income / Expenses(1.56M)(1.52M)(2.24M)(1.83M)(1.3M)
Income Before Tax1.26M130K1.85M5.06M10.62M
Pre-Tax Margin1.2%0.1%1.5%3.8%7.4%
Income Tax Expense(163K)112K979K2.71M4M
Net Income1.42M18K872K2.35M6.63M
Net Margin1.4%0.0%0.7%1.7%4.6%
EPS (Basic)0.070.000.040.110.32
EPS (Diluted)0.060.000.040.110.31
Weighted Avg Shares20.52M20.65M21.02M21.27M20.66M
Weighted Avg Shares (Diluted)22.05M21.55M21.65M21.71M21.1M

InfuSystem Holdings, Inc.

AMEX:INFU

Intrinsic Alpha fair value

Locked

Current Price

$14.67

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.